Robert C. Andrade
Net Worth

Last updated:

What is Robert C. Andrade net worth?

The estimated net worth of Mr. Robert C. Andrade is at least $4,079,081 as of 18 Nov 2024. He owns shares worth $840,424 as insider, has earned $1,056,407 from insider trading and has received compensation worth at least $2,182,250 in Fennec Pharmaceuticals Inc..

What is the salary of Robert C. Andrade?

Mr. Robert C. Andrade salary is $311,750 per year as Chief Financial Officer in Fennec Pharmaceuticals Inc..

How old is Robert C. Andrade?

Mr. Robert C. Andrade is 50 years old, born in 1975.

What stocks does Robert C. Andrade currently own?

As insider, Mr. Robert C. Andrade owns shares in one company:

Company Title Shares Price per share Total value
Fennec Pharmaceuticals Inc. (FENC) Chief Financial Officer 104,271 $8.06 $840,424

What does Fennec Pharmaceuticals Inc. do?

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

FENC logo
FENC
Fennec Pharmaceuticals Inc.
$8.06

Robert C. Andrade insider trading

Fennec Pharmaceuticals Inc.

Mr. Robert C. Andrade has made 10 insider trades between 2018-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 323,961 units of FENC stock on 13 Aug 2020. As of 18 Nov 2024 he still owns at least 104,271 units of FENC stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common shares 15,816 $2.45 $38,749
Option
Stock Options 15,816 $2.45 $38,749
Purchase
Common shares 12,500 N/A N/A
Sale
Common shares 13,975 $10.9 $152,341
Sale
Common shares 13,975 $11 $153,697
Sale
Common shares 15,000 $10.41 $156,150
Sale
Common shares 15,000 $10.64 $159,600
Sale
Common shares 7,500 $8.82 $66,150
Option
Common shares 25,000 $2.45 $61,250
Option
Common Shares 25,000 $2.45 $61,250
Sale
Common shares 7,500 $8.97 $67,275
Sale
Common shares 10,000 $8.99 $89,900
Sale
Common shares 5,500 $9.61 $52,866
Sale
Common shares 5,500 $9.58 $52,662
Sale
Common shares 11,000 $9.62 $105,765
Option
Common shares 323,961 $1.85 $599,328
Option
Common Stock 17,050 $1.44 $24,552

Fennec Pharmaceuticals key executives

Fennec Pharmaceuticals Inc. executives and other stock owners filed with the SEC: